Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (603707.SS) SHH

Currency In CNY

AD

Valuation

Market Cap14.59B
Enterprise Value15.55B
P/E Ratio26.93
PEG Ratio-0.89
Price/Sales Ratio3.3
Price/Book Ratio1.87
Enterprise/Revenue3.4
Enterprise/EBITDA19.09

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.12
Operating Margin0.15
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.07

Income Statement

Revenue3.97B
Revenue/Share2.44
Gross Profit1.46B
EBITDA1B
Net Income581.54M
Diluted EPS0.36

Balance Sheet

Total Cash3.44B
Total Cash/Share2.13
Total Debt2.57B
Total Debt/Equity0.37
Current Ratio2.15
Book Value Per Share4.3

Price History

52-Week Change-21.46
52-Week High10.46
52-Week Low6.72
Moving Average 50 Days7.95
Moving Average 200 Days8.63

Statistics

Average Volume11.69M
Shares Outstanding1.62B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.1
Trailing Annual Dividend Yield1.24
Payout Ratio0.51
Last Split Factor13:10
Last Split DateJuly 11, 2022
AD